Investors are ignoring Lotus Health Group's limited growth, hoping for a business turnaround. However, if recent revenue trends continue, shareholders' investments could be at risk and potential investors may pay an excessive premium.

The company's high P/S ratio and slower-than-industry revenue growth indicate potential share price risk. Investors banking on a turnaround could face disappointment.

Lotus Health Group's high EPS growth rate and reasonable CEO pay make it a good investment, though some risks have been identified.